Patents by Inventor Achim SCHÄFFLER

Achim SCHÄFFLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE
    Publication number: 20170281648
    Abstract: The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: November 18, 2016
    Publication date: October 5, 2017
    Inventor: Achim Schaeffler
  • Delayed-release glucocorticoid treatment of rheumatoid disease
    Patent number: 9504699
    Abstract: The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: November 29, 2016
    Assignee: HZNP Limited
    Inventor: Achim Schaeffler
  • DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE
    Publication number: 20150141388
    Abstract: The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: December 8, 2014
    Publication date: May 21, 2015
    Inventor: Achim Schaeffler
  • Delayed-release glucocorticoid treatment of rheumatoid disease
    Patent number: 8920838
    Abstract: Provided are methods for the treatment of a rheumatic disease, such as rheumatoid arthritis, ankylosating spondylitis and/or polymyalgia rheumatic, by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof wherein the treatment is administered once daily for at least about two weeks. Also provided are methods for the treatment of osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof wherein the treatment is administered once daily for at least about two weeks.
    Type: Grant
    Filed: April 10, 2013
    Date of Patent: December 30, 2014
    Assignee: Horizon Pharma AG
    Inventor: Achim Schaeffler
  • DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF ASTHMA
    Publication number: 20140348918
    Abstract: The present invention refers to the treatment of asthma by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: June 17, 2014
    Publication date: November 27, 2014
    Inventors: Stephan WITTE, Achim SCHAEFFLER
  • DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID ARTHRITIS BY IMPROVING SIGNS AND SYMPTOMS, SHOWING MAJOR OR COMPLETE CLINICAL RESPONSE AND BY PREVENTING FROM JOINT DAMAGE
    Publication number: 20140349980
    Abstract: The present invention refers to the treatment of a patient suffering from rheumatoid arthritis by showing a reduction in signs and symptoms, a major or complete clinical response (remission) or even prevention of structural damages to the joints by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: June 16, 2014
    Publication date: November 27, 2014
    Inventor: Achim Schäffler
  • Tablets with Site- and Time- Controlled Gastrointestinal Release of Active Ingredient
    Publication number: 20120213910
    Abstract: The present invention describes a pharmaceutical dosage form with site- and time-controlled gastrointestinal release of active ingredient.
    Type: Application
    Filed: March 15, 2012
    Publication date: August 23, 2012
    Applicant: Jagotec AG
    Inventors: Achim Schaeffler, Pascal Grenier, Guy Vergnault
  • DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE
    Publication number: 20120070499
    Abstract: The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: July 5, 2011
    Publication date: March 22, 2012
    Inventor: Achim Schaeffler
  • DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF ASTHMA
    Publication number: 20100222312
    Abstract: The present invention refers to the treatment of asthma by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: January 26, 2010
    Publication date: September 2, 2010
    Applicant: NITEC PHARMA AG
    Inventors: Stephan WITTE, Achim Schäffler
  • DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID ARTHRITIS BY IMPROVING SIGNS AND SYMPTOMS, SHOWING MAJOR OR COMPLETE CLINICAL RESPONSE AND BY PREVENTING FROM JOINT DAMAGE
    Publication number: 20100196427
    Abstract: The present invention refers to the treatment of a patient suffering from rheumatoid arthritis by showing a reduction in signs and symptoms, a major or complete clinical response (remission) or even prevention of structural damages to the joints by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: February 1, 2010
    Publication date: August 5, 2010
    Applicant: NITEC PHARMA AG
    Inventor: Achim SCHÄFFLER
  • Delayed-Release Glucocorticoid treatment of Rheumatoid Disease
    Publication number: 20080076743
    Abstract: The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
    Type: Application
    Filed: August 3, 2007
    Publication date: March 27, 2008
    Applicant: Nitec Pharma AG
    Inventor: Achim SCHAEFFLER
  • Tablets with site- and time-controlled gastrointestinal release of active ingredient
    Publication number: 20060057200
    Abstract: The present invention describes a pharmaceutical dosage form with site- and time-controlled gastrointestinal release of active ingredient.
    Type: Application
    Filed: September 1, 2005
    Publication date: March 16, 2006
    Applicant: NITEC PHARMA AG
    Inventor: Achim Schaeffler